Header

UZH-Logo

Maintenance Infos

Publications for Vollenweider, F X

Navigate back| Up a level
Export as
Group by:
Number of items: 57.

2019

Dornbierer, Dario A; Kometer, Michael; Von Rotz, Robin; Studerus, Erich; Gertsch, Jürg; Gachet, M Salomé; Vollenweider, Franz X; Seifritz, Erich; Bosch, Oliver G; Quednow, Boris B (2019). Effects of gamma-hydroxybutyrate on neurophysiological correlates of performance and conflict monitoring. European Neuropsychopharmacology, 29(4):539-548.

2018

Barrett, Frederick S; Preller, Katrin H; Herdener, Marcus; Janata, Petr; Vollenweider, Franz X (2018). Serotonin 2A receptor signaling underlies LSD-induced alteration of the neural response to dynamic changes in music. Cerebral Cortex, 28(11):3939-3950.

Grimm, O; Kraehenmann, R; Preller, K H; Seifritz, E; Vollenweider, F X (2018). Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination. European Neuropsychopharmacology, 28(6):691-700.

Preller, Katrin H; Schilbach, Leonhard; Pokorny, Thomas; Flemming, Jan; Seifritz, Erich; Vollenweider, Franz X (2018). Role of the 5-HT Receptor in Self- and Other-Initiated Social Interaction in Lysergic Acid Diethylamide-Induced States: A Pharmacological fMRI Study. Journal of Neuroscience, 38(14):3603-3611.

2017

Pokorny, Thomas; Preller, Katrin H; Kometer, Michael; Dziobek, Isabel; Vollenweider, Franz X (2017). Effect of psilocybin on empathy and moral decision-making. International Journal of Neuropsychopharmacology, 20(9):747-757.

Lewis, Candace R; Preller, Katrin H; Kraehenmann, Rainer; Michels, Lars; Staempfli, Philipp; Vollenweider, Franz X (2017). Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow. NeuroImage, 159:70-78.

Kraehenmann, Rainer; Pokorny, Dan; Vollenweider, Leonie; Preller, Katrin H; Pokorny, Thomas; Seifritz, Erich; Vollenweider, Franz X (2017). Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation. Psychopharmacology, 234(13):2031-2046.

von Rotz, Robin; Kometer, Michael; Dornbierer, Dario; Gertsch, Jürg; Salomé Gachet, M; Vollenweider, Franz X; Seifritz, Erich; Bosch, Oliver G; Quednow, Boris B (2017). Neuronal oscillations and synchronicity associated with gamma-hydroxybutyrate during resting-state in healthy male volunteers. Psychopharmacology, 234(13):1957-1968.

Preller, Katrin H; Herdener, Marcus; Pokorny, Thomas; Planzer, Amanda; Kraehenmann, Rainer; Stämpfli, Philipp; Liechti, Matthias E; Seifritz, Erich; Vollenweider, Franz X (2017). The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation. Current Biology, 27(3):451-457.

Kraehenmann, Rainer; Pokorny, Dan; Aicher, Helena; Preller, Katrin H; Pokorny, Thomas; Bosch, Oliver G; Seifritz, Erich; Vollenweider, Franz X (2017). LSD increases primary process thinking via serotonin 2A receptor activation. Frontiers in Pharmacology, 8:814.

2016

Preller, Katrin H; Vollenweider, Franz X (2016). Phenomenology, structure, and dynamic of psychedelic states. In: Preller, K H; Vollenweider, Franz X. Current Topics in Behavioral Neurosciences. Springer-Verlag Berlin Heidelberg 2016: Springer, 1-35.

Kometer, Michael; Vollenweider, Franz X (2016). Serotonergic hallucinogen-induced visual perceptual alterations. In: Kometer, Michael; Vollenweider, F X. Current Topics in Behavioral Neurosciences. Springer-Verlag Berlin Heidelberg 2016: Springer, 1-26.

Preller, Katrin H; Pokorny, Thomas; Hock, Andreas; Kraehenmann, Rainer; Stämpfli, Philipp; Seifritz, Erich; Scheidegger, Milan; Vollenweider, Franz X (2016). Effects of serotonin 2A/1A receptor stimulation on social exclusion processing. Proceedings of the National Academy of Sciences of the United States of America, 113(18):5119-5124.

Pokorny, Thomas; Preller, Katrin H; Kraehenmann, Rainer; Vollenweider, Franz X (2016). Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience. European Neuropsychopharmacology, 26(4):756-766.

Kraehenmann, Rainer; Schmidt, André; Friston, Karl; Preller, Katrin H; Seifritz, Erich; Vollenweider, Franz X (2016). The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. NeuroImage: Clinical, 11:53-60.

2015

Kometer, Michael; Pokorny, Thomas; Seifritz, Erich; Vollenweider, Franz X (2015). Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. Psychopharmacology, 232(19):3663-3676.

Bernasconi, Fosco; Kometer, Michael; Pokorny, Thomas; Seifritz, Erich; Vollenweider, Franz X (2015). The electrophysiological effects of the serotonin 1A receptor agonist buspirone in emotional face processing. European Neuropsychopharmacology, 25(4):474-482.

Schmid, Yasmin; Enzler, Florian; Gasser, Peter; Grouzmann, Eric; Preller, Katrin H; Vollenweider, Franz X; Brenneisen, Rudolf; Müller, Felix; Borgwardt, Stefan; Liechti, Matthias E (2015). Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects. Biological Psychiatry, 78(8):544-553.

Kraehenmann, Rainer; Preller, Katrin H; Scheidegger, Milan; Pokorny, Thomas; Bosch, Oliver G; Seifritz, Erich; Vollenweider, Franz X (2015). Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biological Psychiatry, 78(8):572-581.

2014

Bernasconi, Fosco; Schmidt, André; Pokorny, Thomas; Kometer, Michael; Seifritz, Erich; Vollenweider, Franz X (2014). Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin. Cerebral Cortex, 24(12):3221-3231.

Ort, Andres; Kometer, Michael; Rohde, Judith; Seifritz, Erich; Vollenweider, Franz X (2014). The role of GABAB receptors in human reinforcement learning. European Neuropsychopharmacology, 24(10):1606-1614.

Csomor, Philipp A; Preller, Katrin H; Geyer, Mark A; Studerus, Erich; Huber, Theodor; Vollenweider, Franz X (2014). Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry. Neuropsychopharmacology, 39(10):2485-2496.

2013

Kometer, Michael; Schmidt, André; Jäncke, Lutz; Vollenweider, Franz X (2013). Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations. Journal of Neuroscience, 33(25):10544-10551.

Preller, Katrin H; Ingold, Nina; Hulka, Lea M; Vonmoos, Matthias; Jenni, Daniela; Baumgartner, M R; Vollenweider, F X; Quednow, Boris B (2013). Increased sensorimotor gating in recreational and dependent cocaine users is modulated by craving and attention-deficit/hyperactivity disorder symptoms. Biological Psychiatry, 73(3):225-234.

Schmidt, André; Diaconescu, Andreea O; Kometer, Michael; Friston, Karl J; Stephan, Klaas E; Vollenweider, Franz X (2013). Modeling ketamine effects on synaptic plasticity during the mismatch negativity. Cerebral Cortex, 23(10):2394-2406.

Holstein, Dominique H; Vollenweider, Franz X; Geyer, Mark A; Csomor, Phillip A; Belser, Nadine; Eich, Dominique (2013). Sensory and sensorimotor gating in adult attention-deficit/hyperactivity disorder (ADHD). Psychiatry Research, 205(1-2):117-126.

Schmidt, André; Kometer, Michael; Bachmann, Rosilla; Seifritz, Erich; Vollenweider, Franz X (2013). The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. Psychopharmacology, 225(1):227-239.

2012

Studerus, E; Gamma, A; Kometer, M; Vollenweider, F X (2012). Prediction of psilocybin response in healthy volunteers. PLoS ONE, 7(2):e30800.

Quednow, Boris B; Treyer, V; Hasler, F; Dörig, N; Wyss, M T; Burger, C; Rentsch, K M; Westera, G; Schubiger, P A; Buck, A; Vollenweider, F X (2012). Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [(18)F]altanserin positron emission tomography. NeuroImage, 59(4):3922-3932.

Kraehenmann, Rainer; Vollenweider, Franz X; Seifritz, Erich; Kometer, Michael (2012). Crowding deficits in the visual periphery of schizophrenia patients. PLoS ONE, 7(9):e45884.

Schmidt, A; Bachmann, R; Kometer, M; Csomor, P A; Stephan, K E; Seifritz, E; Vollenweider, F X (2012). Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments. Neuropsychopharmacology, 37(4):865-875.

Kometer, Michael; Schmidt, André; Bachmann, Rosilla; Studerus, Erich; Seifritz, Erich; Vollenweider, Franz X (2012). Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Biological Psychiatry, 72(11):898-906.

Quednow, Boris B; Kometer, M; Geyer, M A; Vollenweider, F X (2012). Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology, 37(3):630-640.

2011

Studerus, E; Kometer, M; Hasler, F; Vollenweider, F X (2011). Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. Journal of Psychopharmacology, 25(11):1434-1452.

Kometer, M; Cahn, B R; Andel, D; Carter, O L; Vollenweider, F X (2011). The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations. Biological Psychiatry, 69(5):399-406.

2010

Studerus, E; Gamma, A; Vollenweider, F X (2010). Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS ONE, 5(8):e12412.

Hysek, C M; Vollenweider, F X; Liechti, M E (2010). Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy). Emergency Medicine Journal (EMJ), 27(8):586-589.

Holstein, D H; Vollenweider, F X; Jäncke, Lutz; Schopper, C; Csomor, P A (2010). P50 suppression, prepulse inhibition, and startle reactivity in the same patient cohort suffering from posttraumatic stress disorder. Journal of Affective Disorders, 126(1-2):188-197.

Roser, P; Vollenweider, F X; Kawohl, W (2010). Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists. World Journal of Biological Psychiatry, 11(2 Pt 2):208-219.

Hilti, C C; Delko, T; Orosz, A T; Thomann, K; Ludewig, S; Geyer, M A; Vollenweider, F X; Feldon, J; Cattapan-Ludewig, K (2010). Sustained attention and planning deficits but intact attentional set-shifting in neuroleptic-naïve first-episode schizophrenia patients. Neuropsychobiology, 61(2):79-86.

Vollenweider, F X; Kometer, M (2010). The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nature Reviews. Neuroscience, 11(9):642-651.

2009

Hasler, F; Studerus, E; Lindner, K; Ludewig, S; Vollenweider, F X (2009). Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA. Journal of Psychopharmacology, 23(8):923-935.

Quednow, Boris B; Schmechtig, A; Ettinger, U; Petrovsky, N; Collier, D A; Vollenweider, F X; Wagner, M; Kumari, V (2009). Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study. Biological Psychiatry, 66(6):614-620.

Hasler, F; Kuznetsova, O F; Krasikova, R N; Cservenyak, T; Quednow, Boris B; Vollenweider, F X; Ametamey, S M; Westera, G (2009). GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies. Applied Radiation and Isotopes, 67(4):598-601.

Csomor, P A; Yee, B K; Feldon, J; Theodoridou, A; Studerus, E; Vollenweider, F X (2009). Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients. Schizophrenia Bulletin, 35(1):244-255.

2008

Geyer, M A; Vollenweider, F X (2008). Serotonin research: contributions to understanding psychoses. Trends in Pharmacological Sciences, 29(9):445-453.

Csomor, P A; Yee, B K; Vollenweider, F X; Feldon, J; Nicolet, T; Quednow, Boris B (2008). On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behavioral Neuroscience, 122(4):885-900.

Quednow, Boris B; Csomor, P A; Chmiel, J; Beck, T; Vollenweider, F X (2008). Sensorimotor gating and attentional set-shifting are improved by the μ-opioid receptor agonist morphine in healthy human volunteers. International Journal of Neuropsychopharmacology, 11:655-669.

Wackermann, J; Wittmann, M; Hasler, F; Vollenweider, F X (2008). Effects of varied doses of psilocybin on time interval reproduction in human subjects. Neuroscience Letters, 435(1):51-55.

Cattapan-Ludewig, K; Ludewig, S; Messerli, N; Vollenweider, F X; Seitz, A; Feldon, J; Paulus, M P (2008). Decision-making dysregulation in first-episode schizophrenia. Journal of Nervous and Mental Disease, 196(2):157-160.

Csomor, P A; Stadler, R R; Feldon, J; Yee, B K; Geyer, M A; Vollenweider, F X (2008). Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology, 33(3):497-512.

Vollenweider, F X (2008). Multidimensional approach to sensory gating functions and cognition in humans. In: Gustafson, R; Eberhard, J. The diagnostic concept of schizophrenia: via the laboratory to the clinic: report based on a conference held in Zurich, Switzerland 6th-7th December 2007. Stockholm: H. Lundbeck AB, 33-44.

Vollenweider, F X (2008). Struktur und Neurobiologie der Halluzinogenerfahrung. In: Jungaberle, H; Gasser, P; Weinhold, J; Verres, V. Therapie mit psychoaktiven Substanzen. Bern: Hans Huber, 111-130.

2007

Carter, Olivia L; Hasler, Felix; Pettigrew, John D; Wallis, Guy M; Liu, Guang B; Vollenweider, Franz X (2007). Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans. Psychopharmacology, 195(3):415-424.

2005

Carter, Olivia L; Burr, David C; Pettigrew, John D; Wallis, Guy M; Hasler, Felix; Vollenweider, Franz X (2005). Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. Journal of Cognitive Neuroscience, 17(10):1497-1508.

2004

Hasler, Felix; Grimberg, Ulrike; Benz, Marco A; Huber, Theo; Vollenweider, Franz X (2004). Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study. Psychopharmacology, 172(2):145-156.

2003

Umbricht, D; Vollenweider, F X; Schmid, L; Grübel, C; Skrabo, A; Huber, T; Koller, R (2003). Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology, 28(1):170-181.

This list was generated on Tue Jun 18 04:49:52 2019 CEST.